DYN - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Dyne Therapeutics

Dyne Pharma - logo grafis emiten DYN

The development of a lifelong therapy for muscular dystrophies ensures sales stability for Dyne Therapeutics, Inc. (DYN). The intensity of quarterly EPS growth visualizes this potential, where the -40.40 mark characterizes this parameter. Complex patents for oligonucleotide delivery strengthen the business foundation, creating high barriers to entry. However, access to global capital and clinics remains sensitive to geopolitical risks.

Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Dyne Therapeutics (DYN): kanggo periode 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Dyne Therapeutics (DYN)

- nilai pasar lan prakiraan target analis:
Analisis komprehensif perusahaan:Dyne Therapeutics, Inc. - DYN
Barang unggulan dyne-tx.com

Asset managers evaluate the operational efficiency of Dyne Therapeutics, Inc. (DYN) through net income dynamics. This metric measures the percentage change in earnings per share between the current and previous quarter. By analyzing the growth rate of quarterly earnings per share, investors identify the gap between market expectations and actual returns. While molecular design automation accelerates development, slow clinical trials constrain growth. The stability of this indicator confirms the fundamental resilience of the business.

Pesaing wigati

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|SRRK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Centessa Corp (CNTA)|EWTX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Rapport Pharma RAPP|Alumis Pharma - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ZVRA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Contineum Therapeutics, Inc.|LRMR: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Capricor Therapeutics CAPR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TRDA|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Channel PTHS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MediciNova Inc. (MNOV)|SER - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Apimeds Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan AEON Biopharma, Inc.|NLSP (NLS Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BNOX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan FSD Pharma|Wutah bathi EPS kuartalan Reata